Through co-culture of T cells and myeloma cells from RPMI-8226 cell line, we found that tumor-binding T cells were increased after YBX1 knockdown in RPMI-8226, which indicated enhanced myeloma-T cells interaction when reducing YBX1 expression (Additional file 1: Fig. S14D, E). This evidence concerns the gene YBX1 and neoplasm.